Asian Journal of Case Reports in Surgery

Giant Prostate Cancer: A Clinical Enigma

H. Krishna Moorthy *

Institute of Nephro-Urology, Lourdes Hospital, Kochi, 682 012, India.

Lal Darsan

Institute of Nephro-Urology, Lourdes Hospital, Kochi, 682 012, India.

Ashwin Krishnamoorthy

Regional Cancer Centre, Thiruvananthapuram, 695 011, India.

Anupama Chithra

Apollo Hospitals Bannerghatta, Amalodbhavi Nagar, Naga, Bangalore, 560 076, India.

Thulasi P.

Urology Surgical Suite, Lakshmi Hospital, Ernakulam, 682 016, India.

*Author to whom correspondence should be addressed.

---

Abstract

Prostate is an accessory male sexual organ, which can produce clinical illnesses in the elderly, in the form of benign enlargement, cancers or infections. Although giant prostatic hyperplasia has been described as an entity in literature, prostate cancers reaching such giant propositions without producing local symptoms or metastases is a rarity. We present reports of three cases of giant prostate cancers managed in our centre.

Keywords: Giant prostate cancer, androgen deprivation therapy, benign prostatic enlargement, urinary outflow obstruction

---

---

---

References

Maliakal J, Mousa EE, Menon V. Giant prostatic hyperplasia: Fourth largest prostate reported in medical literature. Sultan Qaboos Univ Med J. 2014;14:e253–e256

Wadstein T. The largest surgically removed hypertrophied prostate. J Am Med Assoc. 1938;110:509.

Mandaliya H, Sung J, Hill J, Samali R, George M. Prostate cancer: Cases of rare presentation and rare metastasis. Case Rep Oncol. 2015; 8(3):526–29. Available:https://doi.org/10.1159/000442045

Fujimoto Y, Yamaha M, Maeda S, Takeuchi T, Ito Y, Kuriyama M, Ban Y, Nishiura T. A case of giant prostate cancer. Hinyokika Kiyo. 1984;30(7):925-30.

Azzi P, Bossé D, Cagiannos I, Borowy-Borowski P, Tiberi D. Primary adenosquamous carcinoma of the prostate with rectal invasion. Case Reports in Urology. 2022;7613482. Available:https://doi.org/10.1155/2022/7613482

Alanee S, Moore A, Nutt M, Holland B, Dynda D, El-Zawahry A, et al. Contemporary incidence and mortality rates of neuroendocrine prostate cancer. Anticancer Res. 2015;35:4145–4150.

Basatac C, Sağlam S, Aktepe F, Akpinar H. Primary large cell prostate neuroendocrine carcinoma with central and nephrogenic diabetes insipidus. Int Braz J Urol. 2020;46(5):859–63. DOI: 10.1590/S1677-5538.IBJU.2019.0180

Parwani AV, Herawi M, Epstein JI. Pleomorphic giant cell adenocarcinoma of the prostate: report of 6 cases. Am J Surg Pathol. 2006;30(10):1254-9. DOI:10.1097/01.pas.0000209841.77595.4b.PMID: 17001156

Barloon TJ, Foderaro AE, Kramolowsky EV. Giant prostate carcinoma: Computed tomography findings and review of previous reports. J Comput Tomogr. 1988;12(1):49-53. DOI: 10.1016/0149-936x(88)90030-6.

Gupta SS, Martini A, Wagaskar VG, Tewari AK. Prostate cancer in a patient with giant prostatic hyperplasia: The robotic approach to a difficult problem. J Endourol Case Rep. 2019; 5(3):99–101.